CASE REPORTS IN HEMATOLOGY

eISSN: 2090-6579pISSN: 2090-6560
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
Overview
  • Publisher
    HINDAWI LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    USD 725
  • Publication Time
    13
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Topics Covered

Bone marrow
Thalassemia
Rare case
Hemoglobin
Bromodomain
Central nervous system
Blast Crisis
Hemophagocytic lymphohistiocytosis
Primary Hepatic Lymphoma
Hematopoietic stem cell transplantation
Paroxysmal nocturnal hemoglobinuria
Immune thrombocytopenia
Cytogenetic Techniques
Dexamethasone
Heparin
Jak2 mutation
Myeloid sarcoma
CNS Involvement
Diffuse large B-cell lymphoma
Dasatinib

Recently Published Papers

Year-wise Publication

FAQs

Since when has CASE REPORTS IN HEMATOLOGY been publishing? Faqs

The CASE REPORTS IN HEMATOLOGY has been publishing since 2011 till date.

How frequently is the CASE REPORTS IN HEMATOLOGY published? Faqs

CASE REPORTS IN HEMATOLOGY is published Continuous publication.

Who is the publisher of CASE REPORTS IN HEMATOLOGY? Faqs

The publisher of CASE REPORTS IN HEMATOLOGY is HINDAWI LTD.

How can I view the journal metrics of CASE REPORTS IN HEMATOLOGY on editage? Faqs

For the CASE REPORTS IN HEMATOLOGY metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of CASE REPORTS IN HEMATOLOGY? Faqs

The eISSN number is 2090-6579 and pISSN number is 2090-6560 for CASE REPORTS IN HEMATOLOGY.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Bone marrow, Thalassemia, Rare case, Hemoglobin, Bromodomain, Central nervous system, Blast Crisis, Hemophagocytic lymphohistiocytosis, Primary Hepatic Lymphoma, Hematopoietic stem cell transplantation, Paroxysmal nocturnal hemoglobinuria, Immune thrombocytopenia, Cytogenetic Techniques, Dexamethasone, Heparin, Jak2 mutation, Myeloid sarcoma, CNS Involvement, Diffuse large B-cell lymphoma, Dasatinib.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.